Clinical Remission and Reduction of Circulating Nephritic Factors by Combining Rituximab With Belimumab in a Case of Complement Factor 3 Glomerulopathy
Kidney Int Rep. 2024 Feb 24;9(6):1919-1922.
doi: 10.1016/j.ekir.2024.02.1402.
eCollection 2024 Jun.
1 Center of Expertise for Lupus, Vasculitis and Complement-mediated Systemic disease (LuVaCs), Department of Nephrology, Leiden University Medical Center, Leiden, The Netherlands.
2 Department of Nephrology and Leiden Transplant Center, Leiden University Medical Center, Leiden, The Netherlands.
3 Department of Nephrology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
4 Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands.